Several tumors are known to exhibit increased EGFR activity, such as glioblastomas, lung cancer, breast, ovarian prostatic, pancreatic cancers, etc. EGFR is also associated with worse prognosis in some cancers such as cancer of the ovary, cervix and bladder (24). The gene discussed is EGFR; the disease is pancreatic neoplasm.